AR051636A1 - Vacunas multivalentes para la gripe aviar - Google Patents

Vacunas multivalentes para la gripe aviar

Info

Publication number
AR051636A1
AR051636A1 ARP050104219A ARP050104219A AR051636A1 AR 051636 A1 AR051636 A1 AR 051636A1 AR P050104219 A ARP050104219 A AR P050104219A AR P050104219 A ARP050104219 A AR P050104219A AR 051636 A1 AR051636 A1 AR 051636A1
Authority
AR
Argentina
Prior art keywords
strains
multivalent vaccines
avian flu
subtype
dose
Prior art date
Application number
ARP050104219A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR051636A1 publication Critical patent/AR051636A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Una composicion de vacuna y un método el cual e efectivo para prevenir o mejorar la infeccion por Virus de Gripe Aviar están establecidos en la presente. La vacuna contiene al menos dos cepas inactivadas de virus de gripe aviar, en donde el total de hemaglutinina (HA) combinada es al menos aproximadamente 200 HA/dosis de la composicion de vacuna, y en donde cada una de las cepas presenta al menos aproximadamente 128 HA/dosis, y además en donde una de las cepas tiene el mismo subtipo HA que aquél del virus de desafío, y en donde al menos una de las cepas tiene un subtipo NA diferente que el virus de desafío.
ARP050104219A 2004-10-07 2005-10-06 Vacunas multivalentes para la gripe aviar AR051636A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61670704P 2004-10-07 2004-10-07
US64845905P 2005-01-31 2005-01-31

Publications (1)

Publication Number Publication Date
AR051636A1 true AR051636A1 (es) 2007-01-31

Family

ID=36148890

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104219A AR051636A1 (es) 2004-10-07 2005-10-06 Vacunas multivalentes para la gripe aviar

Country Status (17)

Country Link
US (1) US8067013B2 (es)
EP (1) EP1796720B1 (es)
JP (1) JP5105524B2 (es)
KR (1) KR101370464B1 (es)
CN (1) CN101035559B (es)
AP (1) AP2167A (es)
AR (1) AR051636A1 (es)
AU (1) AU2005294322A1 (es)
BR (1) BRPI0516542B1 (es)
CA (1) CA2581355C (es)
ES (1) ES2467094T3 (es)
MX (1) MX2007004004A (es)
MY (1) MY153290A (es)
NZ (1) NZ553975A (es)
TW (1) TWI365074B (es)
WO (1) WO2006041978A2 (es)
ZA (1) ZA200702876B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495139A (zh) * 2005-11-10 2009-07-29 迪娃解决方案股份有限公司 鉴别治疗组合物
US9072701B2 (en) 2006-04-21 2015-07-07 St. Jude Children's Research Hospital Avian influenza viruses, vaccines, compositions, formulations, and methods
WO2008048984A2 (en) * 2006-10-18 2008-04-24 St. Jude Children's Research Hospital Methods and compositions for preparing a universal influenza vaccine
CL2008000747A1 (es) * 2007-03-16 2008-04-25 Wyeth Corp Composicion de vacuna que comprende una primera y una segunda cepa inactivada del virus de la influenza aviar; metodo para vacunar un ave.
GB0810305D0 (en) * 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
US9421251B2 (en) 2008-06-25 2016-08-23 Novartis Ag Rapid responses to delayed booster immunisations
TWI444195B (zh) 2008-10-08 2014-07-11 Pokka Corp Anti-avian influenza virus agents and products containing anti-avian influenza virus agents
EP3303571A4 (en) * 2015-06-04 2018-10-17 The University of Hong Kong Live-attenuated virus and methods of production and use
KR101964044B1 (ko) 2018-03-14 2019-04-02 인제대학교 산학협력단 재조합 아데노바이러스를 이용한 다가형 인플루엔자 생백신 플랫폼

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) * 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US6159472A (en) * 1998-11-16 2000-12-12 Akzo Nobel N.V. Intradermal Avian immunization with inactivated vaccines
AU2002253542B2 (en) 2002-04-12 2007-06-07 Ilaria Capua Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

Also Published As

Publication number Publication date
NZ553975A (en) 2010-04-30
CN101035559B (zh) 2011-08-17
AP2007003955A0 (en) 2007-07-30
KR20070059180A (ko) 2007-06-11
MY153290A (en) 2015-01-29
TW200617166A (en) 2006-06-01
AP2167A (en) 2010-11-12
EP1796720B1 (en) 2014-04-23
EP1796720A2 (en) 2007-06-20
WO2006041978A2 (en) 2006-04-20
AU2005294322A1 (en) 2006-04-20
CA2581355C (en) 2016-01-26
BRPI0516542B1 (pt) 2015-11-17
BRPI0516542A (pt) 2008-09-09
US8067013B2 (en) 2011-11-29
TWI365074B (en) 2012-06-01
ES2467094T3 (es) 2014-06-11
ZA200702876B (en) 2008-09-25
JP5105524B2 (ja) 2012-12-26
US20060204976A1 (en) 2006-09-14
KR101370464B1 (ko) 2014-03-06
MX2007004004A (es) 2007-05-10
CN101035559A (zh) 2007-09-12
CA2581355A1 (en) 2006-04-20
WO2006041978A3 (en) 2006-08-03
JP2008515906A (ja) 2008-05-15

Similar Documents

Publication Publication Date Title
AR051636A1 (es) Vacunas multivalentes para la gripe aviar
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
WO2017191258A9 (en) Influenza mrna vaccines
Layton et al. Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets
AR052625A1 (es) Nueva composicion
AR036039A1 (es) Composicion de vacuna para el virus de la influenza
JP2009511084A5 (es)
AR056566A1 (es) Vacunas y procedimientos para tratar la gripe canina
MX2023000411A (es) Vacuna combinada de sars-cov-2 e influenza.
CO6160335A2 (es) Vacuna
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
BRPI0814899A2 (pt) Composição, vacina, metodo para amenizar um ou mais sintomas associados à infecção com o virus da influenza em um individuo e método para reduzir a probabilidade de infecção com o virus da influeza em um individuo"
ES2562774T3 (es) Vacunas para la gripe basadas en el virus del mosaico de la papaya
CL2018002692A1 (es) Vacuna bivalente contra el virus de gripe porcina.(divisional solicitud 201701961)
AR083361A1 (es) Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
MX351380B (es) Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino.
BR112015022582A2 (pt) molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo
PE20170429A1 (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9
AR056712A1 (es) Composicion y vacuna efectiva para tratar prevenir o mejorar la inoculacion del virus de la influenza canina metodo pra generar un inmunogen del virus dela influenza equina o del virus de la influenza canina modelo de la inoculacion util para determinar la eficacia de la composicion contra el virus
BR112019006802A2 (pt) compostos e métodos para diagnóstico e tratamento de infecções virais
EA201400235A1 (ru) Вакцины против гриппа на основе н5
RU2017140856A (ru) Стратегия вакцинации против вируса свиного гриппа вакциной на основе наночастиц
AR106057A1 (es) Composición con efecto antiviral, composición farmacéutica
CL2020002876A1 (es) Vacuna contra la bronquitis infecciosa (divisional de la solicitud no. 201803420)
AR065765A1 (es) Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias

Legal Events

Date Code Title Description
FB Suspension of granting procedure